ATC/DDD

ATC/DDD index H02CA

You are here: Home > ATC/DDD > H > H02 > H02C

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- H
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
- H02
CORTICOSTEROIDS FOR SYSTEMIC USE
- H02C
ANTIADRENAL PREPARATIONS

H02CA

Anticorticosteroids

ATC/DDD code H02CA for Anticorticosteroids

Trilostane used in Cushing's syndrome is classified in this group.

Mifeprostone used in Cushing’s syndrome is classified in G03XB.

Metyrapone used in Cushing’s syndrome is classified in V04CD.

Ketoconazole used in Cushing´s syndrome is classified in J02AB.

The DDD of trilostan is based on the treatment of Cushing's syndrome.

H02CA01
Trilostane
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us